BDX

Seite 1 von 1
neuester Beitrag: 26.10.20 22:16
eröffnet am: 22.05.15 20:02 von: Tamakoschy Anzahl Beiträge: 25
neuester Beitrag: 26.10.20 22:16 von: neymar Leser gesamt: 10189
davon Heute: 3
bewertet mit 1 Stern

22.05.15 20:02
1

2298 Postings, 3921 Tage TamakoschyBDX

Manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products

Becton, Dickinson & Co. is a global medical technology company.

The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

The company operates through three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences.

The BD Medical segment produces medical devices that are used in a wide range of healthcare settings.

This segment product include needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes.

The BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect a broad range of infectious diseases, healthcare-associated infections and cancers.

This segment products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; and plated media.

The BD Biosciences segment produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes.

This segment product include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing.

Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

http://de.4-traders.com/BECTON-DICKINSON-AND-CO-11801/unternehmen/

http://www.bd.com/investors/

 

02.01.16 10:35
1

7 Postings, 1867 Tage FinanceEngineerBecton steigert die Dividende

Hallo,

Becton steigert wieder die Dividende:
http://www.finanzen.net/nachricht/aktien/...-44-Jahr-in-Folge-4622607

Ich habe mich auch mal ausführlich mit Becton beschäftigt, finde es ist ein super langfrist Investment und man sollte hier bei Kursschwäche immer nachkaufen.

http://finance-engineer.de/...n-das-dividendendepot-becton-dickinson/

Gruß Ralph  

22.06.16 23:28

380 Postings, 1794 Tage CabriofahrerRuhig

Interessanter Wert, dennoch so Ruhig hier?  

30.06.16 18:12

216 Postings, 2352 Tage DeluraNa ja

ich hab Becton de facto auf der Watchlist - dauert aber noch was (muss sparen) - Sch....  

06.02.18 20:04

2298 Postings, 3921 Tage TamakoschyQ1 Erwartungen übertroffen

Becton Dickinson and (NYSE:BDX) reported earnings of $2.48 per share beating Walls Streets expectations.

02/06/2018 | 09:32am EST
Becton Dickinson and (NYSE:BDX) reported Q1 2018 earnings this Morning, coming in at $2.48 per share, beating Wall Street?s estimates of $2.41 per Share. Revenue for the quarter came in at $3.08 billion beating analyst estimates of $3.05 billionRecent Insider Trading for Becton Dickinson and (NYSE:BDX)

Weiter hier:  http://www.4-traders.com/...beating-Walls-Streets-expectati-25939869/  

22.06.18 07:59

10 Postings, 900 Tage James8Tamakoschy...

Vielen Dank das du hier immer fleißig die Links postest!

Gerne würde mich aber deine persönliche Meinung zum Unternehmen interessieren. Ich bin bereits investiert aber leider viel zu spät und erst bei 130? eingestiegen...derzeit überlege ich aufzustocken da ich 100% von dem Unternehmen überzeugt bin. Die Übernahme C.R.Bard wird Unmengen an Geld einspülen und die Dividende wird sicher wieder kräftiger erhöht werden .

Wo siehst du den Burggraben bei BDX?
Wie siehst du die nahe/ferne Zukunft (Demografischer Wandel und Auswirkungen)?
Wie siehst du BDX im vergleich zur Konkurrenz aufgestellt?  

29.10.18 17:03

1122 Postings, 4159 Tage ParadiseBirdguter Kauf bei 190 oder etwas drüber

 
Angehängte Grafik:
chart_3years_bectondickinson.png (verkleinert auf 54%) vergrößern
chart_3years_bectondickinson.png

06.11.18 21:36

2298 Postings, 3921 Tage TamakoschyQ4

https://www.marketscreener.com/...scal-4Q-Earnings-Snapshot-27554369/

For the fiscal year 2019, the company now expects sales growth of 8.5% to 9.5%. It also guides adjusted diluted earnings to be between $12.05 and $12.15 a share.

https://www.marketscreener.com/...oss-Provides-FY19-Outlook-27554522/  

05.02.19 20:32

2298 Postings, 3921 Tage TamakoschyQ1 Erwartungen übertroffen -Kurs sinkt trotzdem

05.11.19 19:29

2298 Postings, 3921 Tage TamakoschyQ4

https://www.marketscreener.com/...scal-4Q-Earnings-Snapshot-29517361/

FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Tuesday reported fiscal fourth-quarter net income of $150 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had profit of 41 cents. Earnings, adjusted for one-time gains and costs, came to $3.31 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $3.30 per share.
The medical device manufacturer posted revenue of $4.58 billion in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $4.57 billion.
For the year, the company reported profit of $1.22 billion, or $3.89 per share. Revenue was reported as $17.29 billion.
Becton Dickinson expects full-year earnings in the range of $12.50 to $12.65 per share.
Becton Dickinson shares have increased 16% since the beginning of the year, while the Standard & Poor's 500 index has risen 23%. The stock has risen 11% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BDX at

 

13.12.19 17:15

1122 Postings, 4159 Tage ParadiseBirdAusbruch aus aufsteigendem Dreieck

 
Angehängte Grafik:
chart_3years_bectondickinson.png (verkleinert auf 54%) vergrößern
chart_3years_bectondickinson.png

06.02.20 14:57

2298 Postings, 3921 Tage TamakoschyNach Ausbruch wieder eingefangen Q1

https://www.marketscreener.com/...scal-1Q-Earnings-Snapshot-29950888/

Becton Dickinson: Fiscal 1Q Earnings Snapshot


02/06/2020 | 06:09am EST
FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Thursday reported fiscal first-quarter net income of $278 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had profit of 87 cents. Earnings, adjusted for non-recurring costs and restructuring costs, came to $2.65 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $2.63 per share.
The medical device manufacturer posted revenue of $4.22 billion in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $4.17 billion.
Becton Dickinson expects full-year earnings in the range of $11.90 to $12.10 per share.  

22.06.20 22:08

2265 Postings, 5498 Tage Mathi0304Hallo

Ich bin dann hier mal long investiert....  

01.10.20 18:46

2613 Postings, 949 Tage neymarBecton Dickinson

08.10.20 12:20

2613 Postings, 949 Tage neymarBecton Dickinson

26.10.20 22:16

2613 Postings, 949 Tage neymarBecton Dickinson

   Antwort einfügen - nach oben

  3 Nutzer wurden vom Verfasser von der Diskussion ausgeschlossen: Ciriaco, phre22, stahlfaust

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
SAP SE716460
BioNTechA2PSR2
Amazon906866
Apple Inc.865985
TeslaA1CX3T
NEL ASAA0B733
BYD Co. Ltd.A0M4W9
BayerBAY001
Allianz840400
AlibabaA117ME
NIOA2N4PB
JinkoSolar Holdings Co Ltd Sponsored Amercian Deposit Receipt Repr 2 ShsA0Q87R
Daimler AG710000
BASFBASF11
Lufthansa AG823212